Successful human islet isolation utilizing recombinant collagenase

被引:46
作者
Brandhorst, H
Brandhorst, D
Hesse, F
Ambrosius, D
Brendel, M
Kawakami, Y
Bretzel, RG
机构
[1] Univ Giessen, Dept Med 3, D-35385 Giessen, Germany
[2] Roche Diagnost GMBH, Pharma Res Penzberg, Dept Biochem, Penzberg, Germany
关键词
D O I
10.2337/diabetes.52.5.1143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The enzymatic dissociation of acinar tissue by collagenase is a substantial step in the isolation of pancreatic islets. Although essential collagenase components have been purified, the variability in the activity of different batches limits long-term reproducibility of isolation success. The utilization of purified recombinant proteases would solve this problem. In the present study, pancreases from multiorgan donors were dissociated by means of digestion-filtration using either Liberase III (n = 51) or a recombinant collagenase blend (n = 25). No significant differences were found regarding islet yield before and after purification, the percent of exocrine-attached islets, and final purity. However, the ratio between islet equivalents and islet numbers indicated a lesser fragmentation in islets isolated with recombinant collagenase (P < 0.01). In contrast, viability was slightly higher in islets isolated with Liberase (92.3 +/- 0.8 vs. 85.6 +/- 2.9%; P < 0.05). Insulin release during static glucose incubation was not different between experimental groups. Islet transplantation into diabetic nude mice resulted in sustained normoglycemia in either group until the graft was removed. These results demonstrated that viable human islets can be isolated using recombinant collagenase. Final optimization of this enzyme blend would offer continuous reproducibility of isolation success.
引用
收藏
页码:1143 / 1146
页数:4
相关论文
共 21 条
  • [1] HUMAN ISLET ISOLATION IN 104 CONSECUTIVE CASES - FACTORS AFFECTING ISOLATION SUCCESS
    BENHAMOU, PY
    WATT, PC
    MULLEN, Y
    INGLES, S
    WATANABE, Y
    NOMURA, Y
    HOBER, C
    MIYAMOTO, M
    KENMOCHI, T
    PASSARO, EP
    ZINNER, MJ
    BRUNICARDI, FC
    [J]. TRANSPLANTATION, 1994, 57 (12) : 1804 - 1810
  • [2] Assessment of intracellular insulin content during all steps of human islet isolation procedure
    Brandhorst, H
    Brandhorst, D
    Brendel, MD
    Hering, BJ
    Bretzel, RG
    [J]. CELL TRANSPLANTATION, 1998, 7 (05) : 489 - 495
  • [3] Significant progress in porcine islet mass isolation utilizing liberase HI for enzymatic low-temperature pancreas digestion
    Brandhorst, H
    Brandhorst, D
    Hering, BJ
    Bretzel, RG
    [J]. TRANSPLANTATION, 1999, 68 (03) : 355 - 361
  • [4] Brendel M. D., 2001, INT ISLET TRANSPLANT, V9, P1
  • [5] BURTSCHER H, Patent No. 0677586
  • [6] BURTSCHER H, Patent No. 9822574
  • [7] CAVANAGH TJ, 1994, PANCREATIC ISLET TRA, V1, P39
  • [8] Fetterhoff TJ, 1995, TRANSPLANT P, V27, P3282
  • [9] Gill JF, 1995, TRANSPLANT P, V27, P3276
  • [10] Hesse F, 1995, TRANSPLANT P, V27, P3287